Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRO
Marathon Oil Corporation
MRO
|
+$180M |
| 2 |
BHI
Baker Hughes
BHI
|
+$173M |
| 3 |
Dominion Energy
D
|
+$161M |
| 4 |
Kinder Morgan
KMI
|
+$155M |
| 5 |
Marathon Petroleum
MPC
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRX
FOREST LABORATORIES INC
FRX
|
+$177M |
| 2 |
SLB Ltd
SLB
|
+$121M |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$119M |
| 4 |
PepsiCo
PEP
|
+$110M |
| 5 |
Mastercard
MA
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.14% |
| 2 | Healthcare | 12.64% |
| 3 | Financials | 8.59% |
| 4 | Utilities | 7.75% |
| 5 | Technology | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCH
1751
DELISTED
PotlatchDeltic
PCH
| $2.38M | 0.01% |
59,099
+13,973
| +31% | +$583K |
|
|
WW
1752
PUT
DELISTED
WW International
WW
| $2.38M | 0.01% |
86,600
-200
| -0.2% | -$4.57K |
|
|
FPRX
1753
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| $2.38M | 0.01% |
202,433
+94,734
| +88% | +$1.2M |
|
1754
Supernus Pharmaceuticals
SUPN
$2.64B
| $2.37M | 0.01% |
+272,545
| New | +$2.46M |
|
1755
CALL
AbbVie
ABBV
$470B
| $2.35M | 0.01% |
66,100
+62,100
| +1,553% | +$3.45M |
|
1756
XPO
XPO
$22.5B
| $2.35M | 0.01% |
+180,273
| New | +$1.97M |
|
|
SHOR
1757
DELISTED
ShoreTel, Inc.
SHOR
| $2.35M | 0.01% |
352,956
+133,905
| +61% | +$866K |
|
|
FLY
1758
DELISTED
Fly Leasing Limited
FLY
| $2.35M | 0.01% |
183,200
-60,659
| -25% | -$868K |
|
1759
BlackRock TCP Capital
TCPC
$351M
| $2.35M | 0.01% |
146,015
+73,751
| +102% | +$1.28M |
|
1760
Liberty Media Series A
FWONA
$24.1B
| $2.33M | 0.01% |
97,190
-279,253
| -74% | -$6.86M |
|
|
IPHI
1761
DELISTED
INPHI CORPORATION
IPHI
| $2.33M | 0.01% |
162,241
+75,107
| +86% | +$1.09M |
|
|
SCMP
1762
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $2.33M | 0.01% |
358,679
+58,860
| +20% | +$391K |
|
|
TSL
1763
DELISTED
Trina Solar Limited
TSL
| $2.33M | 0.01% |
193,156
-600,664
| -76% | -$7.5M |
|
1764
iShares MSCI Japan ETF
EWJ
$22.6B
| $2.33M | 0.01% |
49,405
+33,757
| +216% | +$1.61M |
|
1765
Bank of America
BAC
$437B
| $2.32M | 0.01% |
136,239
-2,533,083
| -95% | -$40.3M |
|
1766
HealthStream
HSTM
$844M
| $2.32M | 0.01% |
96,758
+68,563
| +243% | +$1.73M |
|
1767
AerCap
AER
$23.2B
| $2.32M | 0.01% |
56,764
-338,524
| -86% | -$15.4M |
|
|
CTRA
1768
DELISTED
Coterra Energy
CTRA
| $2.32M | 0.01% |
71,022
-536,993
| -88% | -$18M |
|
1769
CALL
Edwards Lifesciences
EW
$52.4B
| $2.32M | 0.01% |
136,200
+6,000
| +5% | +$94.7K |
|
|
RVBD
1770
DELISTED
RIVERBED TECHNOLOGY, INC COM
RVBD
| $2.31M | 0.01% |
124,759
+8,062
| +7% | +$152K |
|
|
ARRY
1771
DELISTED
Array Biopharma Inc
ARRY
| $2.31M | 0.01% |
647,452
+116,551
| +22% | +$459K |
|
1772
Rollins
ROL
$17.5B
| $2.31M | 0.01% |
266,156
+170,643
| +179% | +$1.49M |
|
1773
HUB Group
HUBG
$2.4B
| $2.31M | 0.01% |
113,756
-97,504
| -46% | -$2.22M |
|
|
MDR
1774
DELISTED
McDermott International
MDR
| $2.3M | 0.01% |
134,195
+114,195
| +571% | +$2.46M |
|
|
WW
1775
CALL
DELISTED
WW International
WW
| $2.3M | 0.01% |
83,800
-15,000
| -15% | -$342K |
|
Similar funds
Israel Englander's Q3 2014 Portfolio in Review
As of Q3 2014, Israel Englander held 4,400 positions worth $39.5B, up 9.5% from $36.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander deployed $4.94B of net new capital in Q3 2014, opening 1,066 new positions and adding to 1,336 existing holdings. Its largest new stake was St Jude Medical: 1,407,737 shares worth $84.6M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was SLB Ltd, an estimated $121M trimmed.
- Israel Englander's largest Q3 2014 buy was St Jude Medical: 1,407,737 shares worth $84.6M.
- Israel Englander added most to Marathon Oil Corporation in Q3 2014, an estimated $180M increase.
- Israel Englander's biggest Q3 2014 reduction was SLB Ltd, cutting an estimated $121M.
- Israel Englander fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $177M.
- Israel Englander's ten largest holdings make up 11% of its $39.5B portfolio in Q3 2014.
- Israel Englander opened 1,066 new positions and closed 749 in Q3 2014.
- Israel Englander's portfolio value rose 9.5% quarter-over-quarter to $39.5B.
Based on Millennium Management's 13F filing for Q3 2014, filed 14 Nov 2014.